The company plans to show the offerings at the 31st International Meeting on Advance Spine Techniques (IMAST) 2024 this week. Notably, the company plans to unveil its next-generation TriAltis spine system. The posterior thoracolumbar pedicle screw system offers a comprehensive implant portfolio and advanced instrumentation. It also integrates with enabling technology.
Combined with TriAltis navigation-enabled instruments, the system could address unmet needs across complex spine conditions. That includes degenerative, tumor, trauma and deformity pathologies.
J&J’s DePuy Synthes won FDA clearance for the technologies in October 2023.
DePuy Synthes designed TriAltis around three pillars, according to a news release. First, it wanted to enable seamless integration with power and navigaton. Second, it aimed for reliability rooted in the proven legacy of the company’s spine implants. Finally, the company sought to offer a new development platform and consistent user experience across all indicated pathologies.
The company now offers both the TriAltis spine system and the TriAltis navigation-enabled instruments in the U.S.
“We are thrilled to officially launch the TriAltis spine system,” said Russell Powers, worldwide president, spine, DePuy Synthes. “Our dedication to improving patient outcomes and optimizing the surgeon experience is evident in every aspect of this system – from its seamless integration with power and navigation, to its precision in implant placement to drive more efficiency in the operating room. The TriAltis spine system marks a significant stride in the future of surgical excellence, and we’re excited to continue to pioneer innovation that helps to advance the treatment of complex spine conditions for surgeons and their patients.”
